Clinical Trial Update: A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of ALIMTA (pemetrexed) plus irinotecan in previously treated metastatic colorectal cancer is documented; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED